Prosecution Insights
Last updated: April 19, 2026
Application No. 18/559,937

BANDAGE APPLICATOR

Non-Final OA §102§103§112
Filed
Nov 09, 2023
Examiner
DEAK, LESLIE R
Art Unit
3799
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Alma Plus LLC
OA Round
1 (Non-Final)
75%
Grant Probability
Favorable
1-2
OA Rounds
3y 4m
To Grant
93%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allow Rate
693 granted / 924 resolved
+5.0% vs TC avg
Strong +18% interview lift
Without
With
+18.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
43 currently pending
Career history
967
Total Applications
across all art units

Statute-Specific Performance

§101
1.8%
-38.2% vs TC avg
§103
47.9%
+7.9% vs TC avg
§102
25.1%
-14.9% vs TC avg
§112
11.4%
-28.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 924 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 8 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 8 recites the limitation "the central plug" in line 1. There is insufficient antecedent basis for this limitation in the claim. For compact prosecution, the Examiner is interpreting claim 8 to depend from claim 7., Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-6 and 10 are rejected under 35 U.S.C. 102(a)(1) and (a)(2) as being anticipated by WO2020/112073 to Annamarie. With regard to claims 1, 10, Annamarie discloses a bandage applicator comprising an elongated cylinder 114 configured to be inserted in a central lumen of a spool 114, handle 118 that can be telescoped for storage, and the handle is rotatable to the cylinder 114 (see FIGS 1, 1A, ¶0038, 0039, 0043). With regard to claims 2-6, Annamarie discloses a locking mechanism 3, 7, to lock the handle into various releasably locked telescoped positions (see FIGS 2, 3, ¶0024, 0039-41). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim 9 is rejected under 35 U.S.C. 103 as being unpatentable over WO2020/112073 to Annamarie in view of US 2018/0200202 to Joguparthi et al. In the specification and figures, Annamarie suggests the apparatus substantially as claimed by Applicant (see rejections above). With regard to claim 9, the cited prior art does not comprise an arrow indicator. The Examiner finds that the arrow indicator has a functional relationship to the dispenser apparatus, indicating in which direction a user should apply force to achieve a desired configuration. Joguparthi discloses a medicament dispenser with an arrow printed on the safety cap to indicate which direction a user should apply force to achieve a desired configuration. Accordingly, it would have been obvious to a person having ordinary skill in the art at the time of filing to add an arrow indicator as disclosed by Joguparthi to the dispenser disclosed by Annamarie in order to indicate to a user where to apply force, as taught by Joguparthi. Claims 11-13 are rejected under 35 U.S.C. 103 as being unpatentable over WO2020/112073 to Annamarie in view of KR 20210071644 to Yeong et al. In the specification and figures, Annamarie suggests the apparatus substantially as claimed by Applicant (see rejections above). With regard to claims 11-13, Yeong discloses a medicated wound dressing with an adhesive surface on a roller dispenser (see abstract, p2 of English translation, attached). Where a claimed improvement on a device or apparatus is no more than "the simple substitution of one known element for another or the mere application of a known technique to a piece of prior art ready for improvement," the claim is unpatentable under 35 U.S.C. 103(a). Ex Parte Smith, 83 USPQ.2d 1509, 1518-19 (BPAI, 2007) (citing KSR v. Teleflex, 127 S.Ct. 1727, 1740, 82 USPQ2d 1385, 1396 (2007)). Accordingly Applicant claims a combination that only unites old elements with no change in the respective functions of those old elements, and the combination of those elements yields predictable results; absent evidence that the modifications necessary to effect the combination of elements is uniquely challenging or difficult for one of ordinary skill in the art, the claim is unpatentable as obvious under 35 U.S.C. 103(a). Ex Parte Smith, 83 USPQ.2d at 1518-19 (BPAI, 2007) (citing KSR, 127 S.Ct. at 1740, 82 USPQ2d at1396. Accordingly, since the applicant[s] have submitted no persuasive evidence that the combination of the above elements is uniquely challenging or difficult for one of ordinary skill in the art, the claim is unpatentable as obvious under 35 U.S.C. 103(a) because it is no more than the predictable use of prior art elements according to their established functions resulting in the simple substitution of one known element for another or the mere application of a known technique to a piece of prior art ready for improvement. In the instant case, it would have been obvious to a person with ordinary skill in the art at the time of filing to use a medicated self-adhesive wound dressing as disclosed by Yeong on the roller apparatus disclosed by Annamarie because both elements are known in the art and simply put together. Claim 14 is rejected under 35 U.S.C. 103 as being unpatentable over WO2020/112073 to Annamarie in view of KR 20210071644 to Yeong et al, further in view of WO 2022/261201 to Perry. In the specification and figures, the prior art suggests the apparatus substantially as claimed by Applicant (see rejections above). With regard to claim 14, the prior art suggests a bandage with a medical composition, but not a blood-clot promoter. However, Perry discloses a wound dressing that seals a wound and promotes local clot formation (see Perry p11, lines 1-70). It would have been obvious to a person having ordinary skill in the art at the time of filing to add a clot-forming medicament as disclosed by Perry to the bandage dispenser suggested by the prior art in order to promote clot formation, as taught by Perry. Claim 16 is rejected under 35 U.S.C. 103 as being unpatentable over WO2020/112073 to Annamarie in view of EP 1,845,035 to Pavlik. In the specification and figures, the prior art suggests the apparatus substantially as claimed by Applicant (see rejections above). With regard to claim 16, the cited prior art fails to disclose a non-circular dispenser. However, Pavlik discloses a dispenser for web-like material (such as a bandage) wherein the dispenser may be semicircular, rectangular, or triangular, and the web material may not be in a roll (see ¶0107). Where a claimed improvement on a device or apparatus is no more than "the simple substitution of one known element for another or the mere application of a known technique to a piece of prior art ready for improvement," the claim is unpatentable under 35 U.S.C. 103(a). Ex Parte Smith, 83 USPQ.2d 1509, 1518-19 (BPAI, 2007) (citing KSR v. Teleflex, 127 S.Ct. 1727, 1740, 82 USPQ2d 1385, 1396 (2007)). Applicant claims a combination that only unites old elements with no change in the respective functions of those old elements, and the combination of those elements yields predictable results; absent evidence that the modifications necessary to effect the combination of elements is uniquely challenging or difficult for one of ordinary skill in the art, the claim is unpatentable as obvious under 35 U.S.C. 103(a). Ex Parte Smith, 83 USPQ.2d at 1518-19 (BPAI, 2007) (citing KSR, 127 S.Ct. at 1740, 82 USPQ2d at1396. Accordingly, since the applicant[s] have submitted no persuasive evidence that the combination of the above elements is uniquely challenging or difficult for one of ordinary skill in the art, the claim is unpatentable as obvious under 35 U.S.C. 103(a) because it is no more than the predictable use of prior art elements according to their established functions resulting in the simple substitution of one known element for another or the mere application of a known technique to a piece of prior art ready for improvement. In the instant case, it would have been within the skill of a worker in the art at the time of filling to provide the bandage dispenser as disclosed by Annamarie with an irregular shape, as disclosed by Rodriguez, since both elements were known at the time of filing. Allowable Subject Matter Claims 7 and 8 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: Annamarie discloses the dispenser substantially as claimed by Applicant but does not disclose a tensioning element. GB 2,333,506 to Rodriguez discloses a bandage roller dispenser with a means to control the friction between the handle and the axle of the bandage roller in order to create tension, but does not disclose a central plug with a rod section and a dome section. As such, the prior art fails to suggest the combination of elements as claimed by Applicant. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to LESLIE R DEAK whose telephone number is (571)272-4943. The examiner can normally be reached Monday-Friday, 9am to 5:30pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sarah Al-Hashimi can be reached at 571-272-7159. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LESLIE R DEAK/Primary Examiner, Art Unit 3799 4 December 2025
Read full office action

Prosecution Timeline

Nov 09, 2023
Application Filed
Dec 05, 2025
Non-Final Rejection — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599497
IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND METHODS OF USING SAME
2y 5m to grant Granted Apr 14, 2026
Patent 12594186
AQUEOUS HUMOR DRAINAGE DEVICE WITH ADJUSTABLE TUBE DIAMETER
2y 5m to grant Granted Apr 07, 2026
Patent 12575972
GLAUCOMA STENT AND METHODS THEREOF FOR GLAUCOMA TREATMENT
2y 5m to grant Granted Mar 17, 2026
Patent 12569604
METHOD AND DEVICES FOR DETERMINING A TIME POINT FOR MEASURING PRESSURE MEASUREMENTS
2y 5m to grant Granted Mar 10, 2026
Patent 12569654
SYSTEMS AND METHODS FOR TREATMENT OF FLUID OVERLOAD
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
75%
Grant Probability
93%
With Interview (+18.0%)
3y 4m
Median Time to Grant
Low
PTA Risk
Based on 924 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month